NO20032830L - Tetrahydropyridinderivater, fremstilling derav og anvendelse som celleproliferasjonsinhibitorer - Google Patents

Tetrahydropyridinderivater, fremstilling derav og anvendelse som celleproliferasjonsinhibitorer

Info

Publication number
NO20032830L
NO20032830L NO20032830A NO20032830A NO20032830L NO 20032830 L NO20032830 L NO 20032830L NO 20032830 A NO20032830 A NO 20032830A NO 20032830 A NO20032830 A NO 20032830A NO 20032830 L NO20032830 L NO 20032830L
Authority
NO
Norway
Prior art keywords
preparation
cell proliferation
proliferation inhibitors
tetrahydropyridine derivatives
tetrahydropyridine
Prior art date
Application number
NO20032830A
Other languages
English (en)
Norwegian (no)
Other versions
NO20032830D0 (no
Inventor
Guy Georges
Adelbert Grossmann
Olaf Mundigl
Wolfgang Von Der Saal
Tim Sattelkau
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20032830D0 publication Critical patent/NO20032830D0/no
Publication of NO20032830L publication Critical patent/NO20032830L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NO20032830A 2000-12-23 2003-06-20 Tetrahydropyridinderivater, fremstilling derav og anvendelse som celleproliferasjonsinhibitorer NO20032830L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00128487 2000-12-23
PCT/EP2001/015390 WO2002051842A1 (fr) 2000-12-23 2001-12-21 Derives de tetrahydropyridine, leur preparation et leur utilisation en tant qu'inhibiteurs de proliferation cellulaire

Publications (2)

Publication Number Publication Date
NO20032830D0 NO20032830D0 (no) 2003-06-20
NO20032830L true NO20032830L (no) 2003-08-04

Family

ID=8170814

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032830A NO20032830L (no) 2000-12-23 2003-06-20 Tetrahydropyridinderivater, fremstilling derav og anvendelse som celleproliferasjonsinhibitorer

Country Status (27)

Country Link
US (1) US6800638B2 (fr)
EP (1) EP1353921B1 (fr)
JP (1) JP2004516325A (fr)
KR (1) KR100836545B1 (fr)
CN (1) CN1213046C (fr)
AR (1) AR035513A1 (fr)
AT (1) ATE323700T1 (fr)
AU (1) AU2002226397B2 (fr)
BG (1) BG107935A (fr)
BR (1) BR0116402A (fr)
CA (1) CA2431471A1 (fr)
CZ (1) CZ20031940A3 (fr)
DE (1) DE60118975T2 (fr)
EC (1) ECSP034664A (fr)
ES (1) ES2261519T3 (fr)
HU (1) HUP0400554A2 (fr)
IL (1) IL156131A0 (fr)
MA (1) MA26976A1 (fr)
MX (1) MXPA03005713A (fr)
NO (1) NO20032830L (fr)
NZ (1) NZ526189A (fr)
PL (1) PL365531A1 (fr)
RU (1) RU2276140C2 (fr)
SK (1) SK9122003A3 (fr)
WO (1) WO2002051842A1 (fr)
YU (1) YU48803A (fr)
ZA (1) ZA200304264B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6706686B2 (en) 2001-09-27 2004-03-16 The Regents Of The University Of Colorado Inhibition of histone deacetylase as a treatment for cardiac hypertrophy
EP1443928B1 (fr) 2001-10-16 2011-07-27 Sloan-Kettering Institute For Cancer Research Traitement des maladies neurodegeneratives et du cancer du cerveau
WO2003083323A1 (fr) 2002-04-01 2003-10-09 Ranko Rakanovic Élément élastique en caoutchouc
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7250514B1 (en) 2002-10-21 2007-07-31 Takeda San Diego, Inc. Histone deacetylase inhibitors
AU2003900608A0 (en) * 2003-02-11 2003-02-27 Fujisawa Pharmaceutical Co., Ltd. Hdac inhibitor
US7375228B2 (en) 2003-03-17 2008-05-20 Takeda San Diego, Inc. Histone deacetylase inhibitors
EP1633751A1 (fr) * 2003-06-16 2006-03-15 Chroma Therapeutics Limited Derives de carboline et de betacarboline inhibiteurs de l'enzyme hdac
CN1905881A (zh) * 2003-11-26 2007-01-31 阿托恩药品公司 二胺和亚氨二醋酸异羟肟酸衍生物
US20050137234A1 (en) * 2003-12-19 2005-06-23 Syrrx, Inc. Histone deacetylase inhibitors
WO2005065681A1 (fr) * 2003-12-19 2005-07-21 Takeda San Diego, Inc. Derives de n-hydroxy-3-(3-(1h-imidazol-2-yl)-phenyl)-acrylamide et composes associes en tant qu'inhibiteurs d'histone deacetylase pour le traitement du cancer
US7642275B2 (en) 2004-12-16 2010-01-05 Takeda San Diego, Inc. Histone deacetylase inhibitors
JP2008530136A (ja) 2005-02-14 2008-08-07 ミイカナ セラピューティクス インコーポレイテッド ヒストンデアセチラーゼの阻害剤として有用な縮合複素環化合物
GB0509223D0 (en) * 2005-05-05 2005-06-15 Chroma Therapeutics Ltd Enzyme inhibitors
JP2008540574A (ja) * 2005-05-11 2008-11-20 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
CA2615105A1 (fr) * 2005-07-14 2007-01-25 Takeda San Diego, Inc. Inhibiteurs de l'histone deacetylase
EP2275096A3 (fr) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenese par modulation des recepteurs muscariniques
EP2258357A3 (fr) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenèse avec inhibiteur de l'acetylcholinestérase
WO2007047978A2 (fr) 2005-10-21 2007-04-26 Braincells, Inc. Modulation de la neurogenese par inhibition de la pde
EP2314289A1 (fr) 2005-10-31 2011-04-27 Braincells, Inc. Modulation de la neurogenese dont la médiation est assurée par récepteur gaba
EP1976835A2 (fr) * 2006-01-13 2008-10-08 Takeda San Diego, Inc. Inhibiteurs des histone desacetylases
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2021000A2 (fr) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenèse par modulation de l'angiotensine
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
WO2008030651A1 (fr) 2006-09-08 2008-03-13 Braincells, Inc. Combinaisons contenant un dérivé de 4-acylaminopyridine
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
TWI425945B (zh) * 2007-05-28 2014-02-11 Seldar Pharma Inc 四氫異喹啉－１－酮衍生物或其鹽
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
JP5838157B2 (ja) * 2009-07-22 2015-12-24 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイＴｈｅ Ｂｏａｒｄ Ｏｆ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｉｌｌｉｎｏｉｓ Ｈｄａｃ阻害剤およびそれを用いる治療法
CN102153549B (zh) * 2010-12-14 2012-11-14 华东理工大学 γ咔啉化合物、制备方法和用途
CA2908542C (fr) 2013-04-29 2017-08-01 Chong Kun Dang Pharmaceutical Corp. Nouveaux composes pour inhibiteurs selectifs d'histone desacetylases et composition pharmaceutique les comprenant
WO2015051035A1 (fr) 2013-10-01 2015-04-09 The J. David Gladstone Institutes Compositions, systèmes et procédés pour le criblage de médicament de bruit d'expression génétique et leurs utilisations
CN108084178B (zh) * 2018-01-04 2020-09-01 济南大学 一类含有四氢-β-咔碄结构的异羟肟酸类化合物的用途
CN108558653A (zh) * 2018-05-14 2018-09-21 湖南华腾制药有限公司 赛乐西帕中间体及赛乐西帕的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU196758B (en) * 1986-05-21 1989-01-30 Gyogyszerkutato Intezet Process for production of 3-hidroxi-methil-quinolines and medical compositions containing them
WO1990002119A1 (fr) * 1988-08-18 1990-03-08 Banyu Pharmaceutical Co., Ltd. Derives de 1,2,3,4-tetrahydro-isoquinoline
US5369108A (en) * 1991-10-04 1994-11-29 Sloan-Kettering Institute For Cancer Research Potent inducers of terminal differentiation and methods of use thereof
WO1998007421A1 (fr) * 1996-08-16 1998-02-26 Ishihara Sangyo Kaisha, Ltd. Composition medicinale
WO1998015525A1 (fr) * 1996-10-07 1998-04-16 Sumitomo Pharmaceuticals Co., Ltd. Acides hydroxamiques
AUPO721997A0 (en) 1997-06-06 1997-07-03 Queensland Institute Of Medical Research, The Anticancer compounds
JP2003525203A (ja) * 1999-03-22 2003-08-26 ダーウィン・ディスカバリー・リミテッド ヒドロキサムおよびカルボン酸誘導体

Also Published As

Publication number Publication date
YU48803A (sh) 2006-05-25
KR100836545B1 (ko) 2008-06-10
PL365531A1 (en) 2005-01-10
EP1353921A1 (fr) 2003-10-22
EP1353921B1 (fr) 2006-04-19
MXPA03005713A (es) 2003-10-06
US6800638B2 (en) 2004-10-05
HUP0400554A2 (hu) 2004-06-28
CZ20031940A3 (cs) 2003-10-15
CN1483033A (zh) 2004-03-17
JP2004516325A (ja) 2004-06-03
SK9122003A3 (en) 2004-02-03
BG107935A (bg) 2004-08-31
US20040053960A1 (en) 2004-03-18
AR035513A1 (es) 2004-06-02
NO20032830D0 (no) 2003-06-20
CN1213046C (zh) 2005-08-03
ZA200304264B (en) 2004-08-30
DE60118975D1 (de) 2006-05-24
RU2003122190A (ru) 2005-02-27
CA2431471A1 (fr) 2002-07-04
RU2276140C2 (ru) 2006-05-10
AU2002226397B2 (en) 2006-10-05
WO2002051842A1 (fr) 2002-07-04
NZ526189A (en) 2004-10-29
MA26976A1 (fr) 2004-12-20
IL156131A0 (en) 2003-12-23
BR0116402A (pt) 2003-11-11
ECSP034664A (es) 2003-07-25
KR20030063424A (ko) 2003-07-28
ATE323700T1 (de) 2006-05-15
DE60118975T2 (de) 2006-12-21
ES2261519T3 (es) 2006-11-16

Similar Documents

Publication Publication Date Title
NO20032830D0 (no) Tetrahydropyridinderivater, fremstilling derav og anvendelse som celle-proliferasjonsinhibitorer
NO20053356D0 (no) Aminindazolderivater og anvendelse derav som kinaseinhibitorer.
DK1133477T3 (da) Substituerede benzimidazoler og deres anvendelse som parpinhibitorer
DK1268431T3 (da) 3-Cyanoquinoliner, 3-cyano-1,6-naphthyridiner og 3-cyano-1,7-naphthyridiner som proteinkinaseinhibitorer
NO20026010D0 (no) Substituerte quinazolinderivater og deres anvendelse som inhibitorer
NO20006029L (no) Pyrazolinderivater, deres fremstilling og anvendelse som legemidler
DK1095025T3 (da) Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
NO20035298D0 (no) CDK-inhiberende pyrimider, deres fremstilling og deres anvendelse som legemidler
NO20025357D0 (no) Antranylamider og deres anvendelse som legemidler
NO20005146D0 (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
NO20031838D0 (no) Benzokazinonderivater, deres fremstilling og anvendelse
NO20023146D0 (no) Substituerte fenyl-piperazinderivater, deres fremstilling og anvendelse
NO20016404L (no) Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
DK1043307T3 (da) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
DK1150996T3 (da) Nye amidinobenzylaminderivater og deres anvendelse som thrombin-inhibitorer
DK1387838T3 (da) Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
NO20025504L (no) Nye tiokromanderivater og anvendelse derav som trombininhibitorer
NO20030813L (no) Bifenylderivater og deres anvendelse som integrininhibitorer
DK1214302T3 (da) Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere
NO20024107L (no) Tienopyridin derivater, deres fremstilling og anvendelse
NO20025884L (no) 2-aminotiazolinderivater og deres anvendelse som NO- syntaseinhibitorer
DK1215213T3 (da) Bicylliske aminopyrazinonderivater, fremstilling deraf og farmaceutiske sammensætninger, som indeholder disse
IS7961A (is) Díarýlmetýlídenpíperidínafleiður, lyfjablöndur þeirra og notkun þeirra
NO20001782D0 (no) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
DK1200409T3 (da) Substituerede isoquinolinderivater og deres anvendelse som krampestillende midler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application